Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.24.2.u1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Collaboration revenue $ 36,850 $ 18,626 $ 110,550
Operating expenses:        
Research and development 1,727,033 2,409,471 4,538,363 9,972,055
General and administrative 1,801,632 1,542,689 4,156,360 5,330,967
Total operating expenses 3,528,665 3,952,160 8,694,723 15,303,022
Loss from operations (3,528,665) (3,915,310) (8,676,097) (15,192,472)
Other income 4,327,946
Foreign exchange gain (loss) 23,110 (31,432) 39,512 36,517
Net loss $ (3,505,555) $ (3,946,742) $ (4,308,639) $ (15,155,955)
Per share information:        
Net loss per share, basic $ (0.70) $ (2.95) $ (0.96) $ (18.98)
Net loss per share, diluted $ (0.70) $ (2.95) $ (0.96) $ (18.98)
Weighted average shares outstanding, basic 5,037,508 1,335,872 4,481,803 798,711
Weighted average shares outstanding, diluted 5,037,508 1,335,872 4,481,803 798,711